The number of people with susceptibility test result for rifampicin in Senegal
Senegal: The number of people with susceptibility test result for rifampicin was 30.79 in 2021. ◆ Volatile
Latest (2021)
30.79
Change on year
up 86.9%
World rank
132nd
of 146 countries
All-time high
50.44
in 2017
All-time low
9.71
in 2019
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Senegal, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for the number of people with susceptibility test result for rifampicin in Senegal is 30.79, measured in 2021.
That represents a change of up 86.9% on the previous year and down 38.9% over five years.
That places Senegal 132nd out of 146 countries with data for 2021, putting it in the bottom quarter.
The number of people with susceptibility test result for rifampicin in Senegal, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 50.44 | — |
| 2018 | 14.81 | -70.6% |
| 2019 | 9.71 | -34.4% |
| 2020 | 16.48 | +69.6% |
| 2021 | 30.79 | +86.9% |
Senegal compared with similar countries
- Senegal's 30.79 is below the median for lower middle income countries, which is 78.77, 39% of the median. (32 countries reporting)
- Senegal's 30.79 is below the median for Sub-Saharan Africa, which is 61.16, 50% of the median. (32 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 24.99 | 9.71 | 50.44 | 3 |
| 2020s | 23.63 | 16.48 | 30.79 | 2 |
Countries ranked near Senegal
More health data for Senegal
- Un projection of annual infant deaths, annual growth rate -1.58 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.7598 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 835.5 deaths per 1,000 people (2090)
- Number of infants who die before age 1 2,496 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 3 (2025)
- Population ages 00-04, female, annual growth rate 2.42 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0658 units per person (2025)
- Population ages 00-04, male, annual growth rate 1.29 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Senegal?
- The number of people with susceptibility test result for rifampicin in Senegal was 30.79 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Senegal?
- The highest recorded value was 50.44 in 2017.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Senegal?
- The lowest recorded value was 9.71 in 2019.
- How does Senegal rank for the number of people with susceptibility test result for rifampicin?
- Senegal ranks 132nd out of 146 countries with data for 2021.
- Where does this Senegal data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).